HRH2 (histamine receptor H2) is a G-protein coupled receptor that mediates histamine signaling through Gs protein activation, leading to increased intracellular cAMP levels 1. Primarily recognized for regulating gastric acid secretion in parietal cells 1, HRH2 has broader physiological roles beyond the gastrointestinal tract. HRH2 is expressed in diverse tissues including the bladder, where ADRA2A+/HRH2+ interstitial cells may modulate nerve conduction and allergic responses 2. In hepatic and immune contexts, HRH2 activation on cancer-associated fibroblasts promotes hepatocyte growth factor secretion, contributing to cholangiocarcinoma progression 3. HRH2 is significantly upregulated in triple-negative breast cancer (7.18-fold increase) and HER2+ subtypes, with dysregulation of regulatory microRNAs suggesting involvement in tumor progression 4. Clinically, HRH2 antagonists show promise as therapeutic targets. Nizatidine, an HRH2 blocker, demonstrates potential for treating advanced liver disease and hepatocellular carcinoma chemoprevention through effects on hepatocytes and liver macrophages 5. HRH2 is also identified as a potential therapeutic target in Tourette's disorder 6. Additionally, HRH2 receptors in reproductive tissues regulate testicular androgen levels and sperm viability, with implications for fertility impacts of anti-histamine medications 7. The HRH2 rs2067474 polymorphism is common across populations and may influence individual susceptibility to histamine-related conditions 8.